Glenmark Pharmaceuticals board to consider financial statements

19 Oct 2012 Evaluate
Glenmark Pharmaceuticals has informed that a meeting of the board of directors will be held on October 30, 2012, to consider and approve the company’s un-audited financial statements for the second quarter/half year ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Glenmark Pharma Share Price

1970.75 -25.15 (-1.26%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×